Precision Formulation. Trusted Science.
We specialize exclusively in formulation development for the biopharmaceutical and vaccine sectors. From early-stage concept through process optimization and scale-up, our deep scientific expertise ensures that your formulation performs enabling you to move faster, smarter, and with confidence.
What We Do
Partner with PLA to turn complex biologic and vaccine formulation challenges into reliable, scalable solutions.
Our Core Expertise
-
Formulation Strategy & Design – Tailored formulation roadmaps aligned with your therapeutic goals, regulatory timelines and manufacturing realities.
-
Process Development & Optimisation – Leveraging proven methods and emerging technologies to enhance stability, manufacturability and cost-effectiveness.
-
Scale-Up & Tech Transfer Support – Seamless transition from lab to pilot to commercial manufacturing, minimising risk and accelerating timelines.
Scientific Accomplishments at
Merck Research Labs
Investigated lab-scale microfluidic and turbulent vortex mixing technology for the formulation of lipid nanoparticle (LNP) vaccines and adjuvants.
Formulation development advisor for two vaccine formulation programs within Discovery Pharmaceutical Sciences (DPS).
Moved from Merck Vaccine Drug Product Development (VDPD) to Merck Discovery Pharmaceutical Sciences (DPS) to accelerate vaccine formulation development in both DPS & VDPD.
Co-invented 5 novel non-aluminum vaccine adjuvant formulations for Merck pipeline vaccine programs.
Led early formulation development of currently marketed biologic, Zinplava (Bezlotoxumab).
Formulation lead for Merck Enbrel biosimilar drug product image selection team.
Original formulation lead for the Merck vaccine Vaxneuvance® which the FDA has approved for prevention of invasive disease caused by Streptococcus pneumoniae in adults.
Material & Process Compatibility department lead for monoclonal antibody biosimilar program.
Co-inventor of four key Merck Pneumococcal Conjugate Vaccine (PVC) patents that led to Vaxneuvance and Capvaxine
Why Choose PLA
Deep Domain Experience
Our team brings years of direct formulation work in biologics, vaccines and complex modalities.
Client-Focused Partnership
We don’t just hand over a report we collaborate as part of your team, guiding, communicating, and delivering.
Scientific Rigor, Practical Results
We combine cutting-edge formulation science with real-world manufacturability, so the solutions can be implemented.
Flexible &
Agile
Whether you’re a start-up or established biotech, we adapt our model to your size, timeline and budget.
Insights That Drive Innovation
Let’s Talk
Whether you’re developing a new biologic or optimizing an existing vaccine formulation, PLA provides the precision, discipline, and partnership to help you achieve your goals.